Speakers

Dr. Rasha Rezk is a materials engineer innovating biological applications with microfluidic technologies. Her research at the University of York, supported by the BBSRC ICURe programme (recommended for Exploit), has led to the development of the ForCell platform, a novel mechanoporation system leveraging cell mechanics for advanced therapeutics. ForCell enables non-viral, mechanical delivery of diverse cargo into various cell types, with significant potential for advancing drug discovery and cellular therapeutics. Dr. Rezk holds a PhD from the University of Cambridge, where she also held a prestigious Independent Research Fellowship. Rasha, a 2024 graduate of the highly competitive Creation Destruction Lab (Advanced Therapies, Global Stream), is also a Royal Academy of Engineering Enterprise Fellow.